Table 1.
Baseline Patient Demographics and Clinical Characteristics
| Characteristic | Patients (N = 24) |
|
|---|---|---|
| Median | Range | |
| Age, years | 57 | 21-79 |
| Sex, No. of patients | ||
| Male | 14 | |
| Female | 10 | |
| Performance status, No. of patients | ||
| 0-1 | 22 | |
| 2 | 2 | |
| Prior therapy | ||
| No. of patients | 16 | |
| No. of regimens | 2 | 1-6 |
| β2-microglobulin, mg/L | 3.9 | 1.7-10.8 |
| WBC ×109/dL | 24.8 | 0.6-279.5 |
| Platelets ×109/dL | 120 | 9-285 |
| Bone marrow involvement, No. of patients | 21 | |
| Lymphadenopathy, No. of patients | 8 | |
| Splenomegaly | ||
| No. of patients | 9 | |
| Size, cm | 1-10 | |
| Hepatomegaly | ||
| No. of patients | 3 | |
| Size, cm | 1-5 | |